Bengaluru, India

Michael Rajesh Stephen

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Rajesh Stephen. Retrieved from https://idiyas.com/inventor/michael-rajesh-stephen-pg5iqhgv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Rajesh Stephen: Innovator in Pyrimidine Compounds

Introduction

Michael Rajesh Stephen is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrimidine compounds. His innovative approach has led to advancements in pharmaceutical applications.

Latest Patents

Michael holds a patent for "Pyrimidine compounds, compositions, and medicinal applications thereof." This patent encompasses a class of pyrimidine compounds, including their stereoisomers, tautomers, and pharmaceutically acceptable salts. The disclosure also details a process for preparing these compounds and their medicinal applications.

Career Highlights

Michael is currently associated with Blueprint Medicines Corporation, where he continues to explore and develop new medicinal compounds. His work is pivotal in advancing therapeutic options for various medical conditions.

Collaborations

Michael has collaborated with talented individuals such as Naveena Madhyastha and M Naveen Sadhu, contributing to a dynamic research environment.

Conclusion

Michael Rajesh Stephen's innovative work in pyrimidine compounds showcases his dedication to advancing medicinal chemistry. His contributions are expected to have a lasting impact on the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…